Published in Oncogene on May 01, 1987
Independent expression of the transforming amino-terminal domain of SV40 large I antigen from an alternatively spliced third SV40 early mRNA. EMBO J (1993) 1.39
Modulation of p53 protein expression during cellular transformation with simian virus 40. Mol Cell Biol (1987) 1.25
Nuclear subcompartmentalization of simian virus 40 large T antigen: evidence for in vivo regulation of biochemical activities. J Virol (1989) 1.12
Specific interaction of simian virus 40 large T antigen with cellular chromatin and nuclear matrix during the course of infection. J Virol (1987) 1.11
Structural topography of simian virus 40 DNA replication. J Virol (1991) 1.02
Species-specific phosphorylation of mouse and rat p53 in simian virus 40-transformed cells. J Virol (1992) 0.86
Thermally inactivated simian virus 40 tsA58 mutant T antigen cannot initiate viral DNA replication in vitro. J Virol (1990) 0.85
Change in the expression of a nuclear matrix-associated protein is correlated with cellular transformation. Proc Natl Acad Sci U S A (1991) 0.84
Functional interaction of nuclear transport-defective simian virus 40 large T antigen with chromatin and nuclear matrix. J Virol (1990) 0.83
Wild-type p53 enhances efficiency of simian virus 40 large-T-antigen-induced cellular transformation. J Virol (2009) 0.83
Phenotype-specific phosphorylation of simian virus 40 tsA mutant large T antigens in tsA N-type and A-type transformants. J Virol (1991) 0.83
Two conditional tsA mutant simian virus 40 T antigens display marked differences in thermal inactivation. J Virol (1992) 0.80
2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4-carboxamide derivatives as potent inhibitors of CK1δ/ε. Amino Acids (2012) 0.79
The Q300 gene: a novel transcription unit induced in simian virus 40-infected and -transformed mouse cells. J Virol (1991) 0.76
Negative feedback regulation of wild-type p53 biosynthesis. EMBO J (1995) 2.52
Different structural systems of the nucleus are targets for SV40 large T antigen. Cell (1983) 2.18
Antigenic binding sites of monoclonal antibodies specific for simian virus 40 large T antigen. J Virol (1986) 2.11
Preparation of nuclear matrices from cultured cells: subfractionation of nuclei in situ. J Cell Biol (1984) 2.07
A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease. Genes Dev (2001) 2.05
DNA binding properties of murine p53. Oncogene (1988) 1.85
Intermolecular disulfide bonds: an important structural feature of the polyoma virus capsid. Cold Spring Harb Symp Quant Biol (1975) 1.72
Acylated simian virus 40 large T-antigen: a new subclass associated with a detergent-resistant lamina of the plasma membrane. EMBO J (1983) 1.55
Simian virus to (SV40) tumor-specific proteins in nucleus and plasma membrane of HeLa cells infected by adenovirus 2-SV40 hybrid virus Ad2+ND2. Proc Natl Acad Sci U S A (1976) 1.49
Monoclonal antibodies against simian virus 40 tumor antigens: analysis of antigenic binding sites, using adenovirus type 2-simian virus 40 hybrid viruses. J Virol (1981) 1.44
Independent expression of the transforming amino-terminal domain of SV40 large I antigen from an alternatively spliced third SV40 early mRNA. EMBO J (1993) 1.39
Simian virus 40 T-antigen-related cell surface antigen: serological demonstration on simian virus 40-transformed monolayer cells in situ. J Virol (1980) 1.36
p53 Protein exhibits 3'-to-5' exonuclease activity. Cell (1996) 1.36
Intermediate filament systems are collapsed onto the nuclear surface after isolation of nuclei from tissue culture cells. Exp Cell Res (1982) 1.36
IC261, a specific inhibitor of the protein kinases casein kinase 1-delta and -epsilon, triggers the mitotic checkpoint and induces p53-dependent postmitotic effects. Oncogene (2000) 1.36
Domains of simian virus 40 large T-antigen exposed on the cell surface. Virology (1982) 1.29
Cell surface location of simian virus 40-specific proteins on HeLa cells infected with adenovirus type 2-simian virus 40 hybrid viruses Ad2+ND1 and Ad2+ND2. J Virol (1979) 1.28
Simian virus 40 tumor-specific proteins: subcellular distribution and metabolic stability in HeLa cells infected with nondefective adenovirus type 2-simian virus 40 hybrid viruses. J Virol (1977) 1.22
Evidence for free and metabolically stable p53 protein in nuclear subfractions of simian virus 40-transformed cells. Mol Cell Biol (1986) 1.20
A transgenic mouse model for the ductal carcinoma in situ (DCIS) of the mammary gland. Oncogene (2000) 1.18
SV40 T-antigen-related molecules on the surfaces of HeLa cells infected with adenovirus-2-SV40 hybrids and on SV40-transformed cells. Cold Spring Harb Symp Quant Biol (1980) 1.14
Nuclear subcompartmentalization of simian virus 40 large T antigen: evidence for in vivo regulation of biochemical activities. J Virol (1989) 1.12
Specific interaction of simian virus 40 large T antigen with cellular chromatin and nuclear matrix during the course of infection. J Virol (1987) 1.11
Acylation: a new post-translational modification specific for plasma membrane-associated simian virus 40 large T-antigen. FEBS Lett (1983) 1.10
Dissection of transcriptional and non-transcriptional p53 activities in the response to genotoxic stress. Oncogene (2006) 1.10
Relationship among immunodominance of single CD8+ T cell epitopes, virus load, and kinetics of primary antiviral CTL response. J Immunol (1998) 1.09
Interaction of casein kinase 1 delta (CK1delta) with post-Golgi structures, microtubules and the spindle apparatus. Eur J Cell Biol (2000) 1.07
Dissociation of the recombination control and the sequence-specific transactivation function of P53. Oncogene (1999) 1.07
Late nonstructural 100,000- and 33,000-dalton proteins of adenovirus type 2. I. Subcellular localization during the course of infection. J Virol (1981) 1.07
Simian virus 40 specific proteins on surface of HeLa cells infected with adenovirus 2--SV40 hybrid virus Ad2+ND2. Nature (1979) 1.05
Differentiation between intracellular and cell surface glycosyl transferases: galactosyl transferase activity in intact cells and in cell homogenate. Proc Natl Acad Sci U S A (1974) 1.05
The dual role model for p53 in maintaining genomic integrity. Cell Mol Life Sci (1999) 1.04
Specific mismatch recognition in heteroduplex intermediates by p53 suggests a role in fidelity control of homologous recombination. Mol Cell Biol (1998) 1.04
Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53. Oncogene (1999) 1.03
Rb2/p130 is the dominating pocket protein in the p53-p21 DNA damage response pathway leading to senescence. Oncogene (2009) 1.03
Structural topography of simian virus 40 DNA replication. J Virol (1991) 1.02
SV40-transformed cells express SV40 T antigen-related antigens on the cell surface. Virology (1981) 1.02
DNA-conformation is an important determinant of sequence-specific DNA binding by tumor suppressor p53. Oncogene (1997) 1.02
The kinase activity of SV40 large T antigen is mediated by a cellular kinase. EMBO J (1986) 1.01
Upregulation of mdm-2 expression in Meth A tumor cells tolerating wild-type p53. Oncogene (1993) 1.01
Emergence of virus escape mutants after immunization with epitope vaccine. J Virol (1995) 1.01
The versatile interactions of p53 with DNA: when flexibility serves specificity. Cell Death Differ (2006) 1.00
Cooperation of simian virus 40 large and small T antigens in metabolic stabilization of tumor suppressor p53 during cellular transformation. J Virol (1995) 1.00
Membrane interactions of simian virus 40 large T-antigen: influence of protein sequences and fatty acid acylation. Mol Cell Biol (1984) 1.00
Simian virus 40 T- and U-antigens: immunological characterization and localization in different nuclear subfractions of simian virus 40-transformed cells. J Virol (1979) 0.99
Gadd45 beta is a pro-survival factor associated with stress-resistant tumors. Oncogene (2007) 0.99
Abrogation of wild-type p53 mediated growth-inhibition by nuclear exclusion. Oncogene (1996) 0.98
A new sensitive target-bound DNA binding assay for SV40 large T antigen. Virology (1986) 0.97
CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. Oncogene (2011) 0.96
Role of heteroduplex joints in the functional interactions between human Rad51 and wild-type p53. Oncogene (2000) 0.96
Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53. Oncogene (1999) 0.95
Stabilization of the tumor suppressor p53 during cellular transformation by simian virus 40: influence of viral and cellular factors and biological consequences. J Virol (1994) 0.95
Suppression of tumorigenicity of breast cancer cells by transfer of human chromosome 17 does not require transferred BRCA1 and p53 genes. Oncogene (1995) 0.94
Late nonstructural 100,000- and 33,000-dalton proteins of adenovirus type 2. II. Immunological and protein chemical analysis. J Virol (1981) 0.94
Two immunologically distinct human DNA polymerase alpha-primase subpopulations are involved in cellular DNA replication. Mol Cell Biol (2001) 0.94
CD8+ T lymphocyte-mediated antiviral immunity in mice as a result of injection of recombinant viral proteins. J Immunol (1994) 0.93
Immortalization of BALB/c mouse embryo fibroblasts alters SV40 large T-antigen interactions with the tumor suppressor p53 and results in a reduced SV40 transformation-efficiency. Oncogene (1994) 0.92
Regulation of cellular senescence by Rb2/p130. Oncogene (2006) 0.92
MDM2 is a target of simian virus 40 in cellular transformation and during lytic infection. J Virol (1997) 0.92
Mapping of a DNA-binding domain of simian virus 40 T-antigen using non-defective adenovirus 2--simian virus 40 hybrid viruses. FEBS Lett (1982) 0.92
Specific binding of MAR/SAR DNA-elements by mutant p53. Oncogene (1996) 0.91
Interactions of mutant p53 with DNA: guilt by association. Oncogene (2007) 0.91
Specific interaction of mutant p53 with regions of matrix attachment region DNA elements (MARs) with a high potential for base-unpairing. Proc Natl Acad Sci U S A (1998) 0.91
Overexpression of p53 protein during pancreatitis. Br J Cancer (1997) 0.91
Correlation between the conformational phenotype of p53 and its subcellular location. Oncogene (1992) 0.89
Specific complex of the late nonstructural 100,000-dalton protein with newly synthesized hexon in adenovirus type 2-infected cells. Virology (1983) 0.89
Cooperation between p53 and p130(Rb2) in induction of cellular senescence. Cell Death Differ (2006) 0.89
Simian virus 40 (SV40)-specific proteins associated with the nuclear matrix isolated from adenovirus type 2-SV40 hybrid virus-infected HeLa cells carry SV40 U-antigen determinants. J Virol (1978) 0.89
Cell cycle control by p53 in normal (3T3) and chemically transformed (Meth A) mouse cells. I. Regulation of p53 expression. Oncogene (1990) 0.89
SV40 T-antigen-related surface antigen: correlated expression with nuclear T-antigen in cells transformed by an SV40 A-gene mutant. Virology (1980) 0.89
Acylated simian virus 40-specific proteins in the plasma membrane of HeLa cells infected with adenovirus 2-simian virus 40 hybrid virus Ad2+ND2. Virology (1983) 0.89
Progressive reorganization of the host cell cytoskeleton during adenovirus infection. J Virol (1986) 0.88
Detection of simian virus 40 T-antigen-related antigens by a 125I-protein A-binding assay and by immunofluorescence microscopy on the surface of SV40-transformed monolayer cells. J Gen Virol (1981) 0.88
Evidence for transmembrane orientation of acylated simian virus 40 large T antigen. J Virol (1985) 0.88
p53 and mdm2 are expressed independently during cellular proliferation. Oncogene (1994) 0.88
Analysis of simian virus 40 small t antigen-induced progression of rat F111 cells minimally transformed by large T antigen. J Virol (1993) 0.88
Nuclear matrix preparations from liver tissue and from cultured vertebrate cells: differences in major polypeptides. Eur J Cell Biol (1983) 0.88
Cytoplasmic retention of mutant tsp53 is dependent on an intermediate filament protein (vimentin) scaffold. Oncogene (1998) 0.87
Mutant p53 protein, master regulator of human malignancies: a report on the Fifth Mutant p53 Workshop. Cell Death Differ (2011) 0.87
Surface plasmon resonance measurements reveal stable complex formation between p53 and DNA polymerase alpha. Oncogene (1999) 0.87
Species-specific phosphorylation of mouse and rat p53 in simian virus 40-transformed cells. J Virol (1992) 0.86
Analysis of mechanisms controlling the interactions of SV40 large T antigen with the SV40 ORI region. Virology (1988) 0.85
Immunization of mice with the N-terminal (1-272) fragment of simian virus 40 large T antigen (without adjuvants) specifically primes cytotoxic T lymphocytes. Eur J Immunol (1993) 0.85
Phosphorylation of p53 in primary, immortalised and transformed Balb/c mouse cells. Oncogene (1990) 0.85
In vivo acylation of Dictyostelium actin with palmitic acid. EMBO J (1985) 0.85
Identification of genomic DNA sequences bound by mutant p53 protein (Gly245-->Ser) in vivo. Oncogene (2000) 0.85
The proliferation-associated early response gene p22/PRG1 is a novel p53 target gene. Oncogene (1998) 0.84
TGFbeta-induced growth inhibition involves cell cycle inhibitor p21 and pRb independent from p15 expression. Int J Oncol (1999) 0.84
Comparative assessment of the functional p53 status in glioma cells. Anticancer Res (2005) 0.84
Phenotype-specific phosphorylation of simian virus 40 tsA mutant large T antigens in tsA N-type and A-type transformants. J Virol (1991) 0.83
Specific and complex interactions of murine p53 with DNA. Oncogene (1992) 0.83
Immunization with soluble simian virus 40 large T antigen induces a specific response of CD3+ CD4- CD8+ cytotoxic T lymphocytes in mice. Eur J Immunol (1992) 0.83
Species- and tissue-specific expression of the C-terminal alternatively spliced form of the tumor suppressor p53. Nucleic Acids Res (1995) 0.82
High affinity MAR-DNA binding is a common property of murine and human mutant p53. J Cell Biochem (1998) 0.82
Protective immunity in BALB/c mice against the simian virus 40-induced mKSA tumor resulting from injection of recombinant large T antigen. Requirement of CD8+ T lymphocytes. J Immunol (1996) 0.82
Cell-specific transcriptional activation of the mdm2-gene by ectopically expressed wild-type form of a temperature-sensitive mutant p53. Oncogene (1995) 0.82
Similar regulation of the synthesis of adenovirus fiber and of simian virus 40-specific proteins encoded by the helper-defective Ad2+SV40 hybrid viruses Ad2+ND5 and Ad2+ND4del. J Virol (1985) 0.81
The cellular chromatin is an important target for SV40 large T antigen in maintaining the transformed phenotype. Virology (1990) 0.81
Wild-type p53 is not a negative regulator of simian virus 40 DNA replication in infected monkey cells. J Virol (1993) 0.81